103 related articles for article (PubMed ID: 22312906)
41. Purinergic modulation of cardiovascular function in the rat locus coeruleus.
Yao ST; Lawrence AJ
Br J Pharmacol; 2005 Jun; 145(3):342-52. PubMed ID: 15735655
[TBL] [Abstract][Full Text] [Related]
42. [Antagonists of platelet P2 receptors: achievements, problems, and prospects].
Ziganshin AY
Eksp Klin Farmakol; 2010 Apr; 73(4):38-43. PubMed ID: 20486559
[TBL] [Abstract][Full Text] [Related]
43. Dual role of P2 receptors during osteoblast differentiation.
Rodrigues-Ribeiro R; Alvarenga ÉC; Calio ML; Paredes-Gamero EJ; Ferreira AT
Cell Biochem Biophys; 2015 Mar; 71(2):1225-33. PubMed ID: 25384617
[TBL] [Abstract][Full Text] [Related]
44. A putative osmoreceptor system that controls neutrophil function through the release of ATP, its conversion to adenosine, and activation of A2 adenosine and P2 receptors.
Chen Y; Shukla A; Namiki S; Insel PA; Junger WG
J Leukoc Biol; 2004 Jul; 76(1):245-53. PubMed ID: 15107462
[TBL] [Abstract][Full Text] [Related]
45. Purinergic signalling in the cardiovascular system-a tribute to Geoffrey Burnstock.
Ralevic V
Purinergic Signal; 2021 Mar; 17(1):63-69. PubMed ID: 33151503
[TBL] [Abstract][Full Text] [Related]
46. P2 receptors in cancer progression and metastatic spreading.
Di Virgilio F; Falzoni S; Giuliani AL; Adinolfi E
Curr Opin Pharmacol; 2016 Aug; 29():17-25. PubMed ID: 27262778
[TBL] [Abstract][Full Text] [Related]
47. Adenosine triphosphate: a multifaceted chemical signal in the nervous system.
Benarroch EE
Neurology; 2010 Feb; 74(7):601-7. PubMed ID: 20157163
[No Abstract] [Full Text] [Related]
48. Adventures in the pharmacological analysis of P2 receptors.
Fagura MS; Jarvis GE; Dougall IG; Leff P
J Auton Nerv Syst; 2000 Jul; 81(1-3):178-86. PubMed ID: 10869718
[TBL] [Abstract][Full Text] [Related]
49. The Future of Cardiovascular Therapeutics.
MacRae CA; Roden DM; Loscalzo J
Circulation; 2016 Jun; 133(25):2610-7. PubMed ID: 27324356
[No Abstract] [Full Text] [Related]
50. Special Issue of
Zemkova H
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396540
[TBL] [Abstract][Full Text] [Related]
51. [Risks of progression of cerebrovascular pathology associated with the activity of the brain purinergic system].
Barinov EF; Statinova EA; Sokhina VS; Faber TI
Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(10):118-124. PubMed ID: 33244967
[TBL] [Abstract][Full Text] [Related]
52. P2Y14R for inflammation therapy: is it a promising target?
Wang Y; Duan Y
Future Med Chem; 2021 Sep; 13(18):1493-1495. PubMed ID: 34278830
[No Abstract] [Full Text] [Related]
53. P2 receptors meet the immune system.
Di Virgilio F; Borea PA; Illes P
Trends Pharmacol Sci; 2001 Jan; 22(1):5-7. PubMed ID: 11261415
[No Abstract] [Full Text] [Related]
54. How Prof. Burnstock's enthusiasm supported P2 receptor research in Germany.
Hausmann R; Franke H; Schmalzing G
Purinergic Signal; 2021 Mar; 17(1):139-140. PubMed ID: 33543379
[No Abstract] [Full Text] [Related]
55. [Purinergic signaling in cardiovascular system].
Nishimura A; Nishida M
Nihon Yakurigaku Zasshi; 2017; 149(2):84-90. PubMed ID: 28154303
[No Abstract] [Full Text] [Related]
56. Correction to: P2 purinergic receptors regulate the progression of colorectal cancer.
Zhang WJ; Zhang LP; Lin SJ; Wang CY; Le YG
Purinergic Signal; 2024 Jun; 20(3):311. PubMed ID: 38427183
[No Abstract] [Full Text] [Related]
57. European meeting "P2 receptors: new targets for the treatment of osteoporosis".
Jørgensen NR; Boeynaems JM; Di Virgilio F
Purinergic Signal; 2011 Jun; 7(2):275-6. PubMed ID: 21484088
[No Abstract] [Full Text] [Related]
58. The German Research Unit "Neuronal and glial P2 receptors; molecular basis and functional significance".
Schöneberg T; Illes P; Burnstock G
Purinergic Signal; 2010 Jun; 6(2):285-7. PubMed ID: 20806020
[No Abstract] [Full Text] [Related]
59. [Purinergic P2-receptors as potential targets of new pharmaceutical products].
Ziganshin AU
Vestn Ross Akad Med Nauk; 2011; (11):32-8. PubMed ID: 22312906
[TBL] [Abstract][Full Text] [Related]
60. Potential Therapeutic Applications of P2 Receptor Antagonists: From Bench to Clinical Trials.
da Silva Ferreira NC; Alves LA; Soares-Bezerra RJ
Curr Drug Targets; 2019; 20(9):919-937. PubMed ID: 30760187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
